A TRIAL FIBRILLATION (AF) is associated postoperatively with cardiac surgery in 25% to 50% of cases depending on the type of surgery. It occurs in about 25% to 30% of cases with coronary artery bypass graft surgery and in 50% of cases involving valve surgery. 1-4 AF commonly occurs 48 to 72 hours postoperatively. The most consistent predictor of postoperative atrial fibrillation is age. [2][3][4][5] There is a progressive increase in the incidence of AF with each decade of life. 6 Other risk factors that have been associated with postoperative AF include a history of supraventricular tachycardia, 3 preoperative ventricular dysfunction, 3 prolonged cross-clamp time, 3 hypertension, 4 chronic obstructive pulmonary disease, 2 increased Pwave duration preoperatively, 7 mild versus moderate hypothermia during cardiopulmonary bypass (CPB), 6 gender, 3,4,7 increased left atrial size, 6 and the use of CPB. 8 Mechanisms that have been proposed for postoperative AF include the inflammatory response associated with CPB resulting in activation of the sympathetic nervous system, 9 electrophysiologic mechanisms such as reentry or nonuniform atrial refractoriness, 10,11 and activation of the complement system. 12 Postoperative AF has been shown to be associated with delayed extubation and an increase in intensive care unit and hospital length of stay. 2-4,13,14 AF has been found to be an independent predictor of increased hospital length of stay when adjusted for age. 13 This increased length of stay has translated into an increase in hospital costs. 4,15 Postoperative AF has also been linked to compromised cardiac function, 1 ventricular arrhythmias, need for a permanent pacemaker implant, and stroke. 2 Postoperative AF has not been associated, however, with an increase in mortality after cardiac surgery. 2
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TREATMENT OF POSTOPERATIVE ATRIAL FIBRILLATION
The treatment of postoperative AF consists of pharmacologic means aimed primarily at rate control and in certain cases sinus conversion. Direct current cardioversion is required for arrhythmias that manifest hemodynamic instability or are refractory to pharmacologic cardioversion. Multiple antiarrhythmic agents have been used, including calcium channel blockers, ␤-blockers, digoxin, amiodarone, dofetilide, and ibutilide. Agents such as calcium channel blockers, digoxin, and ␤-blockers primarily have been used for rate control and have not been found to be effective for sinus conversion. 1 Amiodarone has been found to be useful in maintaining sinus rhythm after cardioversion with variable efficacy in cardioversion. [16] [17] [18] Dofetilide, a newer class III antiarrhythmic agent used successfully in nonsurgical patients, was found to have limited efficacy in postoperative atrial arrhythmias. 19 Ibutilide, another newer class III antiarrhythmic agent, has been found to be effective in converting postoperative AF to sinus rhythm (15% conversion in placebo compared with 40% to 57% conversion in ibutilide group). 20 Treatment with ibutilide has been associated, however, with ventricular arrhythmias, including an 8% incidence of torsades de pointes. The incidence of torsades de pointes is increased in patients with poor ventricular function. Torsades de pointes that was easily terminated with magnesium and cessation of ibutilide infusion occasionally required direct current cardioversion. 21 Direct current cardioversion, which is the most effective means of sinus conversion for postoperative AF, is usually discouraged in the early postoperative period because of the high rate of recurrence of AF. 1 There has been some debate on when to anticoagulate such patients with persistent AF because of the small increase in the possibility of mural thrombus formation and resulting strokes. 22 The potential for a postoperative intrapericardial bleed must be considered. Anticoagulation may be prudent, however, especially in cases involving valve surgery or in patients with poor ventricular function. 11 In most instances, postoperative AF spontaneously converts to sinus rhythm either in the hospital or shortly after discharge at home. Aggressive attempts to convert such patients to a sinus rhythm should be weighed against the risks involved. 1
SPECIFIC AGENTS FOR ATRIAL FIBRILLATION PROPHYLAXIS

Magnesium
The role of magnesium in the prevention of AF is promising. Many institutions routinely administer magnesium after removal of the cross-clamp to prevent or treat ventricular arrhythmias. Because atrial arrhythmias primarily occur on day 2 to 3, there may be a role for magnesium in larger doses in this period. Magnesium is associated with a low incidence of side effects, which can be monitored by measuring serum magnesium levels and monitoring deep tendon reflexes. Studies have shown a significant decrease in the incidence of postoperative
